ConductScience.org, home

Paper39871069

Kurarinone Mitigates LPS-Induced Inflammatory Osteolysis by Inhibiting Osteoclastogenesis Through the Reduction of ROS Levels and Suppression of the PI3K/AKT Signaling Pathway.

Lv H and 8 others. Inflammation, 2025. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Kurarinone Mitigates LPS-Induced Inflammatory Osteolysis by Inhibiting Osteoclastogenesis Through the Reduction of ROS Levels and Suppression of the PI3K/AKT Signaling Pathway. Papers, record 39871069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39871069

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Kurarinone Mitigates LPS-Induced Inflammatory Osteolysis by Inhibiting Osteoclastogenesis Through the Reduction of ROS Levels and Suppression of the PI3K/AKT Signaling Pathway.
PubMed
Journal
Inflammation
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
3.89, provisional
iCite
Revised in PubMed
2025-11-12
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lv HHao
2Luo HHao
3Tan WWen
4Zhong JJunlong
5Xiong JJiachao
6Liu ZZhiming
7Wu QQin
8Lin SSijian
9Cao KKaihttps://orcid.org/0000-0001-6384-1227

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
OsteogenesisMajor topic
Reactive Oxygen SpeciesMajor topic
Proto-Oncogene Proteins c-aktMajor topic
OsteolysisMajor topic
OsteoclastsMajor topic
FlavonoidsMajor topic
Animals
Lipopolysaccharides
Signal Transduction
Mice
Phosphatidylinositol 3-Kinases
RAW 264.7 Cells
Inflammation

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. 2023A0282Project of Jiangxi Provincial Administration of Traditional Chinese MedicinePubMed
No. 81860473,82360419National Nature Science Foundation of ChinaPubMed
No.8210298001Double-thousand Plan Program of Jiangxi ProvincePubMed
No. YFYLCYJPY202202Clinical Cultivation Project of The First Affiliated Hospital of Nanchang UniversityPubMed
No. GJJ2200182Research Project of Jiangxi Provincial Department of EducationPubMed
No.202310504Research Project of Health Commission of Jiangxi ProvincePubMed

Source PubMed

Download CSV of grants

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112748652Osteoclast differentiation and activation.Nature2003https://conductscience.org/library/papers/12748652PubMed
238776674Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injury.Biomed Pharmacother2024https://conductscience.org/library/papers/38776674PubMed
332927921Osteoblast-Osteoclast Communication and Bone Homeostasis.Cells2020https://conductscience.org/library/papers/32927921PubMed
411786679Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects.Horm Res2001https://conductscience.org/library/papers/11786679PubMed
526065002Mechanisms of Bone Resorption in Periodontitis.J Immunol Res2015https://conductscience.org/library/papers/26065002PubMed
628569732Inflammatory osteolysis: a conspiracy against bone.J Clin Invest2017https://conductscience.org/library/papers/28569732PubMed
735270012Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments.Int J Mol Sci2022https://conductscience.org/library/papers/35270012PubMed
834646138Five-Decade Update on Chemopreventive and Other Pharmacological Potential of Kurarinone: a Natural Flavanone.Front Pharmacol2021https://conductscience.org/library/papers/34646138PubMed
920569521Flavonoids as anti-inflammatory agents.Proc Nutr Soc2010https://conductscience.org/library/papers/20569521PubMed
1019385054Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis.Adv Drug Deliv Rev2009https://conductscience.org/library/papers/19385054PubMed
1138671436PTEN: an emerging target in rheumatoid arthritis?Cell Commun Signal2024https://conductscience.org/library/papers/38671436PubMed
1235641491The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates.Cell Death Dis2022https://conductscience.org/library/papers/35641491PubMed
1331165007The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases.Aging Dis2019https://conductscience.org/library/papers/31165007PubMed
1436235631Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway.Nutrients2022https://conductscience.org/library/papers/36235631PubMed
1537804813Kurarinone exerts anti-inflammatory effect via reducing ROS production, suppressing NLRP3 inflammasome, and protecting against LPS-induced sepsis.Biomed Pharmacother2023https://conductscience.org/library/papers/37804813PubMed
1626998193ROS and ROS-Mediated Cellular Signaling.Oxid Med Cell Longev2016https://conductscience.org/library/papers/26998193PubMed
171664645Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.J Bone Miner Res1991https://conductscience.org/library/papers/1664645PubMed
1836835184Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs.Int J Mol Sci2023https://conductscience.org/library/papers/36835184PubMed
1911450700Organization of cytoskeletal F-actin, G-actin, and gelsolin in the adhesion structures in cultured osteoclast.J Bone Miner Res2001https://conductscience.org/library/papers/11450700PubMed
2021377852Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei--an in vitro efficacy study.Phytomedicine2011https://conductscience.org/library/papers/21377852PubMed

See all 47 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42588190An Inulin-Type Atractylodes Macrocephala Polysaccharide Alleviates Weightlessness-Induced Bone Loss in Association with the Nrf2/HO-1 Pathway.Nutrients2026https://conductscience.org/library/papers/42588190PubMed
42375095Isoschaftoside Inhibits Osteoclastogenesis by Suppressing the NF-κB and MAPK Pathways.Biomol Ther (Seoul)2026https://conductscience.org/library/papers/42375095PubMed
42307068Identifying Shared Key Genes and Cellular Characteristics Between Chronic Periodontitis and Aging Using Integrative Single-Cell and Mendelian Randomization Analyses.Biomed Res Int2026https://conductscience.org/library/papers/42307068PubMed
42291408Kurarinone: From chemistry to pharmacological values-A review.Iran J Basic Med Sci2026https://conductscience.org/library/papers/42291408PubMed
419634836-Hydroxyflavone Attenuates Inflammatory Osteolysis by Inhibiting Osteoclast Activation via the Nrf2 and Calcium Signaling Pathways.Inflammation2026https://conductscience.org/library/papers/41963483PubMed
41646868The Nrf2/HO-1 signaling pathway in arthritis: from molecular mechanisms to therapeutic potential.Front Cell Dev Biol2026https://conductscience.org/library/papers/41646868PubMed
41484074Inflammatory bone loss and signaling pathways in periodontitis: mechanistic insights and emerging therapeutic strategies.Bone Res2026https://conductscience.org/library/papers/41484074PubMed
41153240Association of Hemoglobin to Red Blood Cell Distribution Width Ratio and Total Bone Mineral Density in U.S. Adolescents: The NHANES 2011-2018.Diagnostics (Basel)2025https://conductscience.org/library/papers/41153240PubMed
40667446The role of oxidative balance score in Cardiovascular-Kidney-Metabolic syndrome progression and mortality: insights from NHANES 1999-2020.Front Nutr2025https://conductscience.org/library/papers/40667446PubMed
40309038The potential crosstalk genes and molecular mechanisms between systemic lupus erythematosus and periodontitis.Front Genet2025https://conductscience.org/library/papers/40309038PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39871069

GET https://conductscience.org/api/papers/v1/39871069/references?page=2